Referencias
Holden BA, Fricke TR, Wilson DA, Jong M, Naidoo KS, Sankaridurg P, Wong TY, Naduvilath TJ, Resnikoff S. Global Prevalence of Myopia and High Myopia and Temporal Trends from 2000 through 2050. Ophthalmology. 2016 May;123(5): 1036-1042. https://doi.org/10.1016/j.ophtha.2016.01.006
Cooper J, Tkatchenko AV. A Review of Current Concepts of the Etiology and Treatment of Myopia. Eye Cont Lens. 2018;44(4): 231–247. https://doi.org/10.1097/ICL.0000000000000499
Smith MJ, Walline JJ. Controlling myopia progression in children and adolescents. Adolescent health, medicine and therapeutics. 2015;6: 133–140. https://doi.org/10.2147/AHMT.S55834
Chia A, Tay SA. Clinical Management and Control of Myopia in Children. En: Ang M, Wong T (eds), Updates on Myopia. Singapore: Springer; 2020. https://doi.org/10.1007/978-981-13-8491-2_8
Mori K, Torii H, Fujimoto S, Jiang X, Ikeda SI, Yotsukura E, Koh S, Kurihara T, Nishida K, Tsubota K. The Effect of Dietary Supplementation of Crocetin for Myopia Control in Children: A Randomized Clinical Trial. J Clin Med. 2019;8(8): 1179. https://doi.org/10.3390/jcm8081179
Mori K, Kurihara T, Miyauchi M, Ishida A, Jiang X, Ikeda S, et al. Oral crocetin administration suppressed refractive shift and axial elongation in a murine model of lens-induced myopia. Sci Rep. 2019;9(1): 1–10. http://dx.doi.org/10.1038/s41598-018-36576-w
Cui D, Trier K, Zeng J, Wu K, Yu M, Hu J, et al. Effects of 7-methylxanthine on the sclera in form deprivation myopia in guinea pigs. Acta Ophthalmol. 2011;89(4): 328–334.
Trier K, Munk Ribel-Madsen S, Cui D, Brøgger Christensen, S. Systemic 7-methylxanthine in retarding axial eye growth and myopia progression: a 36-month pilot study. Journal of ocular biology, diseases, and informatics. 2008;1(2-4): 85–93. https://doi.org/10.1007/s12177-008-9013-3
